Compare GDTC & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDTC | MLSS |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8M | 23.7M |
| IPO Year | 2023 | 1995 |
| Metric | GDTC | MLSS |
|---|---|---|
| Price | $1.77 | $0.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 135.8K | ★ 3.2M |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $573,193.00 | ★ $8,929,517.00 |
| Revenue This Year | $5.37 | $16.06 |
| Revenue Next Year | N/A | $14.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 63.03 | 0.59 |
| 52 Week Low | $1.65 | $0.28 |
| 52 Week High | $4.05 | $1.39 |
| Indicator | GDTC | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 40.07 | 49.10 |
| Support Level | $1.72 | $0.31 |
| Resistance Level | $1.88 | $0.32 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 10.33 | 85.05 |
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.